<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03950011</url>
  </required_header>
  <id_info>
    <org_study_id>BDD RAAC-IPC 2016-011</org_study_id>
    <secondary_id>2174848</secondary_id>
    <nct_id>NCT03950011</nct_id>
  </id_info>
  <brief_title>Database for Data Collection in the Context of an Enhanced Recovery After Surgery Program in Oncology Surgery</brief_title>
  <acronym>BDD RAAC</acronym>
  <official_title>Database for Data Collection in the Context of an Enhanced Recovery After Surgery Program in Oncology Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Paoli-Calmettes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Paoli-Calmettes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Enhanced Recovery After Surgery Programs (ERP) includes multimodal approaches of
      perioperative patient's clinical pathways designed to achieve early recovery after surgery
      and a decreased length of hospital stay (LOS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This database would also allow an objective evaluation of the quality of the surgical
      management and the follow-up.

      One of the evaluation criteria will be measured by the quantity and quality of publications
      from this database, and also by the increase in the activity of the service concerned.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">February 28, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Data collection</measure>
    <time_frame>4 years</time_frame>
    <description>Restrospective and prospective data collection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the quality of surgical management</measure>
    <time_frame>4 days</time_frame>
    <description>characteristics of the surgery according to the type of diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative complications</measure>
    <time_frame>4 days</time_frame>
    <description>post-operative complications in hospitalization and post-operative complications after leaving hospital</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Oncology</condition>
  <arm_group>
    <arm_group_label>ERP</arm_group_label>
    <description>Any patient requiring oncologic surgery, including hysterectomy or curettage, posterior pelvectomy, conventional laparoscopic or assisted robotic surgery, or laparotomy for cervical or cervical cancer or ovarian cancer, body or cervix uterus and ovaries as well as benign pathologies or borderline malignancy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Enhanced recovery after surgery program</intervention_name>
    <description>Enhanced Recovery After Surgery Programs (ERP) includes multimodal approaches of perioperative patient's clinical pathways designed to achieve early recovery after surgery and a decreased length of hospital stay (LOS).</description>
    <arm_group_label>ERP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient operated including hysterectomy and or curettage, posterior pelvectomy,
        conventional laparoscopic or assisted robot, or laparotomy at the Paoli-Calmettes Institute
        from 01 2016 to 12 2017, and incrementation from 2018.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient operated including hysterectomy and or curettage, posterior pelvectomy,
             conventional laparoscopic or assisted robot, or laparotomy at the Paoli-Calmettes
             Institute from 01 2016 to 12 2017, and incrementation from 2018.

        Exclusion Criteria:

          -  Non applicable.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>uterine or cervical cancer or ovarian cancer</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dominique Genre</last_name>
    <phone>+33491223778</phone>
    <email>drci.up@ipc.unicancer.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <state>Bouches Du Rhone</state>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Genre, MD</last_name>
      <phone>0033491223778</phone>
      <email>drci.up@ipc.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Eric Lambaudie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Lambaudie E, de Nonneville A, Brun C, Laplane C, N'Guyen Duong L, Boher JM, Jauffret C, Blache G, Knight S, Cini E, Houvenaeghel G, Blache JL. Enhanced recovery after surgery program in Gynaecologic Oncological surgery in a minimally invasive techniques expert center. BMC Surg. 2017 Dec 28;17(1):136. doi: 10.1186/s12893-017-0332-9.</citation>
    <PMID>29282059</PMID>
  </results_reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>September 20, 2018</study_first_submitted>
  <study_first_submitted_qc>May 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2019</study_first_posted>
  <last_update_submitted>May 13, 2019</last_update_submitted>
  <last_update_submitted_qc>May 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Enhanced Recovery After Surgery Program (ERP)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

